​Chr. Hansen enters into partnership with Rheolution Inc.

​Chr. Hansen enters into partnership with Rheolution Inc.
The new products in Chr. Hansen's portfolio offer real-time analytics of the milk coagulation process for optimal value generation
Press Release | Nov 29. 2017 13:05 GMT

New sophisticated analytics technology helps cheesemakers increase overall value from the milk processed – Chr. Hansen obtains global distribution

Chr. Hansen has entered into a partnership with Rheolution Inc. on the global distribution of Rheolution's CoaguSens™ and ElastoSens™ products.

Aimed at cheesemakers, the products offer real-time analytics of the milk coagulation process. In real time and near the vats, they measure the flocculation point (where solid particles are separated from the liquid), the milk gel firmness, as well as the speed of coagulation.

The milk gel-cutting step is often the least controlled step in the cheese making process, but with the insights that this technology can derive, cheesemakers will know precisely the optimal time to cut the cheese curd at a controlled firmness. This will enable them to retain the greatest amount of protein and fat from the milk in their cheese, thus increasing the overall value generated from the milk processed.

Perfect synergy
“Rheolution has chosen Chr. Hansen as its strategic sales partner because of the perfect synergy between the core expertise of the two companies. Rheolution delivers high quality process control instruments and technical support to monitor the coagulation of milk. Chr. Hansen, as a recognized leader in the culture and enzyme industry with a strong focus on innovation, brings valuable expertise on cheese making technology and a global commercialization network.

Together, we look forward to improving the quality and yield of cheese and fresh fermented products. We also hope to benefit the environment by minimizing food waste in the dairy industry,” says Anis Hadj Henni, CEO, Rheolution Inc.

Expands world-class product portfolio
The new partnership not only expands Chr. Hansen’s product portfolio, which already includes top of the line coagulants, cheese cultures and tests, to include real-time data analysis tools. It also strengthens the company’s role as the go-to solutions provider for cheese producers worldwide.

“Our partnership with Rheolution brings us one step closer to the practical use of digitalization to optimize the coagulation in the cheese vat. I am convinced that partnering with Rheolution brings innovative expertise and concrete data processing excellence to the table, and jointly we will make CoaguSens™ the reference technology for the dairy industry and further develop the analytical applications of the products,” says Soeren Herskind, Vice President, Cheese, Chr. Hansen.

CoaguSens™ and ElastoSens™ are already up and running for cheese producers throughout the US, Canada, and Europe. Chr. Hansen expects to further develop these markets and continue to grow reach globally.

“The products are convenient and require very little time to get up and running. We like to refer to them as data driven aids to the art of cheese making – and they come with Chr. Hansen's first rate service and renowned application assistance on the spot,” concludes Herskind.

An innovative response

  • CoaguSens™ is an innovative response to the dairy industry’s need for better control over milk coagulation. 
  • It was designed with cheesemakers for cheesemakers. 
  • CoaguSens™ can be used to automate operations and collect at line production data. The collection and use of this data could reshape the dairy industry by increasing plant efficiency and product quality. 

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world’s most sustainable biotech company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Share this with: